DENTSPLY SIRONA Inc. - Common Stock (XRAY)
9.4600
-0.6300 (-6.24%)
NASDAQ · Last Trade: Nov 7th, 12:14 AM EST
DENTSPLY SIRONA Q3 Earnings Call Highlightsmarketbeat.com
DENTSPLY SIRONA (NASDAQ:XRAY) lowered its full-year earnings outlook after third-quarter sales fell across its dental businesses, as pressure from European distributor inventory reductions, the Middle East conflict and higher freight costs offset progress in parts of its U.S. operations.
The dental
Via MarketBeat · November 6, 2026
DENTSPLY (XRAY) Q3 2026 Earnings Call Transcriptfool.com
Europe and Middle East pressures pulled sales and guidance lower this quarter.
Via The Motley Fool · November 6, 2026
Dentsply Sirona (XRAY) stock trades down, here is why
What happened? Shares of dental products company Dentsply Sirona (NASDAQ:XRAY) fell 7% in the morning session after the company reported a GAAP diluted loss ...
Via StockStory · November 6, 2026
XRAY Q3 2026 deep dive: revenue shortfall and guidance cut amid dental market headwinds
Dental products company Dentsply Sirona (NASDAQ:XRAY) fell short of the market’s revenue expectations in Q3 2026, with sales falling 7.5% year on year to $83...
Via StockStory · November 6, 2026
3 healthcare stocks that concern us
From novel pharmaceuticals to telemedicine, most healthcare companies are on a mission to drive better patient outcomes. Those leading the charge have not on...
Via StockStory · November 5, 2026
Dentsply Sirona (NASDAQ:XRAY) misses Q3 2026 revenue estimates, stock drops 14.4%
Dental products company Dentsply Sirona (NASDAQ:XRAY) fell short of the market’s revenue expectations in Q3 2026, with revenue falling 7.5% year on year to $...
Via StockStory · November 5, 2026
Stryker, Omnicell, Zimmer Biomet, Artivion, and Dentsply Sirona shares are soaring, what you need to know
What happened? A number of stocks jumped in the afternoon session after election results confirmed that Democrats reclaimed majorities in the House and Senat...
Via StockStory · November 4, 2026
Dentsply Sirona (XRAY) Q3 earnings report preview: what to look for
Dental products company Dentsply Sirona (NASDAQ:XRAY) will be reporting earnings this Thursday afternoon. Here’s what to expect. Dentsply Sirona beat analyst...
Via StockStory · November 3, 2026
Dentsply Sirona (XRAY): Buy, Sell, or Hold Post Q2 Earnings?
Dentsply Sirona has gotten torched over the last six months - since April 2026, its stock price has dropped 27.3% to $8.62 per share. This may have investors...
Via StockStory · October 9, 2026
3 Stocks Under $10 Walking a Fine Line
Investors can certainly boost their returns by concentrating on stocks trading between $1 and $10. However, a disciplined approach is necessary because many ...
Via StockStory · September 28, 2026
Q2 Rundown: Dentsply Sirona (NASDAQ:XRAY) Vs Other Dental Equipment & Technology Stocks
The end of the earnings season is always a good time to take a step back and see who shined (and who didn’t). Let’s take a look at how dental equipment & tec...
Via StockStory · September 24, 2026
1 Value Stock with Impressive Fundamentals and 2 Facing Headwinds
Value investing has produced some of the world’s most famous investing billionaires, including Warren Buffett, David Einhorn, and Seth Klarman, who built the...
Via StockStory · September 23, 2026
3 Russell 2000 Stocks We Steer Clear Of
The Russell 2000 (^RUT) is packed with potential breakout stocks, thanks to its focus on smaller companies with high growth potential. However, smaller size ...
Via StockStory · September 11, 2026
1 Healthcare Stock with Promising Prospects and 2 Facing Headwinds
Healthcare companies are pushing the status quo by innovating in areas like drug development and digital health. Shareholders who bet on the industry have be...
Via StockStory · September 3, 2026
1 Stock Under $50 to Research Further and 2 Facing Headwinds
Stocks trading between $10 and $50 can be particularly interesting as they frequently represent businesses that have survived their early challenges. However...
Via StockStory · August 24, 2026
3 Unprofitable Stocks with Open Questions
Unprofitable companies can burn through cash quickly, leaving investors exposed if they fail to turn things around. Without a clear path to profitability, th...
Via StockStory · August 20, 2026
Dentsply Sirona (XRAY) Q2 2026 Earnings Call Transcriptfool.com
Revenue declined 4.1% as restructuring efforts begin to take hold.
Via The Motley Fool · August 14, 2026
The 5 Most Interesting Analyst Questions From Dentsply Sirona’s Q2 Earnings Call
Dentsply Sirona’s second quarter results were met with a negative market reaction, as shares declined following revenue and non-GAAP earnings that exceeded W...
Via StockStory · August 13, 2026
Why Dentsply Sirona (XRAY) Stock Is Trading Lower Today
What Happened? Shares of dental products company Dentsply Sirona (NASDAQ:XRAY) fell 6.8% in the afternoon session after the company reported second-quarter 2...
Via StockStory · August 7, 2026
XRAY Q2 Deep Dive: Turnaround Progress Slowed by Market and Segment Headwinds
Dental products company Dentsply Sirona (NASDAQ:XRAY) announced better-than-expected revenue in Q2 CY2026, but sales fell by 4.1% year on year to $898 millio...
Via StockStory · August 7, 2026
DENTSPLY SIRONA Q2 Earnings Call Highlightsmarketbeat.com
DENTSPLY SIRONA (NASDAQ:XRAY) reported second-quarter 2026 revenue of $898 million, down 4.1% on a reported basis and 6.3% on a constant-currency basis, as the dental products company continued its turnaround plan amid lower volumes in several businesses and distributor inventory reductions in Europ
Via MarketBeat · August 7, 2026
Dentsply Sirona (NASDAQ:XRAY) Beats Q2 CY2026 Sales Expectations
Dental products company Dentsply Sirona (NASDAQ:XRAY) reported Q2 CY2026 results topping the market’s revenue expectations, but sales fell by 4.1% year on ye...
Via StockStory · August 6, 2026
Earnings To Watch: Dentsply Sirona (XRAY) Reports Q2 Results Tomorrow
Dental products company Dentsply Sirona (NASDAQ:XRAY) will be reporting results this Thursday after market hours. Here’s what investors should know. Dentsply...
Via StockStory · August 4, 2026
3 Reasons to Sell XRAY and 1 Stock to Buy Instead
Dentsply Sirona has been treading water for the past six months, recording a small loss of 0.5% while holding steady at $12.66. The stock also fell short of ...
Via StockStory · July 24, 2026
Dental Equipment & Technology Stocks Q1 In Review: Dentsply Sirona (NASDAQ:XRAY) Vs Peers
Wrapping up Q1 earnings, we look at the numbers and key takeaways for the dental equipment & technology stocks, including Dentsply Sirona (NASDAQ:XRAY) and i...
Via StockStory · June 23, 2026